https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-announces-milestone-achievement-in-strategic-u4j1pg9k883u.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-announces-milestone-achievement-in-strategic-u4j1pg9k883u.html?utm_source=stocktitan-bluesky&utm_medium=social
• Holder: State Street
• Stake: 0 → 4.1% (about $18M)
• About 13G: a passive investor, not seeking to influence the company
• Filed: Nov 10 · Schedule 13G
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
• Holder: State Street
• Stake: 0 → 4.1% (about $18M)
• About 13G: a passive investor, not seeking to influence the company
• Filed: Nov 10 · Schedule 13G
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
prismmarketview.com/lilly-puts-a...
https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-announces-q3-2026-financial-results-and-z4d4r4e4qgro.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-announces-q3-2026-financial-results-and-z4d4r4e4qgro.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-to-present-at-upcoming-november-investor-3ax7yrwobu9c.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-to-present-at-upcoming-november-investor-3ax7yrwobu9c.html?utm_source=stocktitan-bluesky&utm_medium=social
• Holder: Bank of America Corp /DE/
• Stake: 7% → 5.4% (about $28M)
• Shares: 15,134,689 → 11,867,012
• Filed: Oct 28 · Schedule 13G/A
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
• Holder: Bank of America Corp /DE/
• Stake: 7% → 5.4% (about $28M)
• Shares: 15,134,689 → 11,867,012
• Filed: Oct 28 · Schedule 13G/A
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-to-report-third-quarter-2026-financial-results-jt7q20hybqs8.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-to-report-third-quarter-2026-financial-results-jt7q20hybqs8.html?utm_source=stocktitan-bluesky&utm_medium=social
www.youtube.com/watch?v=cTmX...
www.youtube.com/watch?v=cTmX...
McCarthy Sean A. (CEO) sold 101,793 shares at an average price of $4.5377 per common share. (Date: 2025-11-06)
McCarthy Sean A. (CEO) sold 101,793 shares at an average price of $4.5377 per common share. (Date: 2025-11-06)
www.youtube.com/watch?v=CtMx...
#愛知 #名古屋 #nagoya #aichi #twiNAGOYA #togo #okazaki #chitter #nishio #gamagori #kasugai #obu #toyokawa #twiHANTOU #twiSETO #twitoyota #138town #anjou #kariya #shinshiro #takahama #toyohashi #inazawa #mikayama
www.youtube.com/watch?v=CtMx...
#愛知 #名古屋 #nagoya #aichi #twiNAGOYA #togo #okazaki #chitter #nishio #gamagori #kasugai #obu #toyokawa #twiHANTOU #twiSETO #twitoyota #138town #anjou #kariya #shinshiro #takahama #toyohashi #inazawa #mikayama
www.biopharmcatalyst.com/news/2026/ca...
www.biopharmcatalyst.com/news/2026/ca...
https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-announces-fda-fast-track-designation-for-855qglgg57qi.html
https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-announces-fda-fast-track-designation-for-855qglgg57qi.html
Read more here: www.onclive.com/view/fda-gra...
Read more here: www.onclive.com/view/fda-gra...
📺 www.youtube.com/watch?v=CTMX...
📺 www.youtube.com/watch?v=CTMX...